ZA9510554B - Substituted 1H-imidazoles - Google Patents
Substituted 1H-imidazolesInfo
- Publication number
- ZA9510554B ZA9510554B ZA9510554A ZA9510554A ZA9510554B ZA 9510554 B ZA9510554 B ZA 9510554B ZA 9510554 A ZA9510554 A ZA 9510554A ZA 9510554 A ZA9510554 A ZA 9510554A ZA 9510554 B ZA9510554 B ZA 9510554B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425211.1A GB9425211D0 (en) | 1994-12-14 | 1994-12-14 | Substituted 1H-imidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9510554B true ZA9510554B (en) | 1996-06-13 |
Family
ID=10765918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9510554A ZA9510554B (en) | 1994-12-14 | 1995-12-12 | Substituted 1H-imidazoles |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5658938A (esLanguage) |
| EP (1) | EP0717037A1 (esLanguage) |
| JP (1) | JPH08208622A (esLanguage) |
| KR (1) | KR960022474A (esLanguage) |
| CN (1) | CN1054376C (esLanguage) |
| AR (1) | AR002257A1 (esLanguage) |
| AU (1) | AU693614B2 (esLanguage) |
| BG (1) | BG63043B1 (esLanguage) |
| BR (1) | BR9505815A (esLanguage) |
| CA (1) | CA2165133A1 (esLanguage) |
| CZ (1) | CZ327195A3 (esLanguage) |
| EE (1) | EE9500064A (esLanguage) |
| FI (1) | FI955927A7 (esLanguage) |
| GB (1) | GB9425211D0 (esLanguage) |
| HU (1) | HUT73980A (esLanguage) |
| IL (1) | IL116325A (esLanguage) |
| IS (1) | IS4311A (esLanguage) |
| MX (1) | MX9505063A (esLanguage) |
| NO (1) | NO305316B1 (esLanguage) |
| NZ (1) | NZ280646A (esLanguage) |
| PL (1) | PL311736A1 (esLanguage) |
| RO (1) | RO113346B1 (esLanguage) |
| RU (1) | RU2156239C2 (esLanguage) |
| SK (1) | SK155095A3 (esLanguage) |
| TW (1) | TW303362B (esLanguage) |
| ZA (1) | ZA9510554B (esLanguage) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
| GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| ZA981080B (en) * | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
| US20030073850A1 (en) * | 1998-08-07 | 2003-04-17 | Altenbach Robert J. | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use |
| US6503935B1 (en) * | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| US6388090B2 (en) | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
| ES2247107T3 (es) | 2000-05-08 | 2006-03-01 | Orion Corporation | Nuevos indanilimidazoles policiclicos con actividad adrenergica. |
| TW200930291A (en) * | 2002-04-29 | 2009-07-16 | Bayer Cropscience Ag | Pesticidal heterocycles |
| US20040266776A1 (en) * | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
| FI20022007A0 (fi) * | 2002-11-08 | 2002-11-08 | Juvantia Pharma Ltd Oy | Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi |
| FI20022159A0 (fi) * | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
| JP2009524618A (ja) * | 2006-01-27 | 2009-07-02 | エフ.ホフマン−ラ ロシュ アーゲー | Cns障害の処置における2−イミダゾールの使用 |
| CA2666762C (en) * | 2006-10-19 | 2014-12-30 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| RU2009112495A (ru) * | 2006-10-19 | 2010-11-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Аминометил-2-имидазолы со сродством к рецепторам, ассоциированным со следовыми аминами |
| CA2668454A1 (en) * | 2006-11-02 | 2008-05-08 | F. Hoffmann-La Roche Ag | Substituted 2-imidazoles |
| KR101134226B1 (ko) * | 2006-11-16 | 2012-04-10 | 에프. 호프만-라 로슈 아게 | 치환된 4-이미다졸 |
| JP2010513238A (ja) * | 2006-12-13 | 2010-04-30 | エフ.ホフマン−ラ ロシュ アーゲー | 微量アミン関連受容体(taar)に対するリガンドとしての新規2−イミダゾール |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| EP2114906B1 (en) * | 2007-02-02 | 2014-08-06 | F. Hoffmann-La Roche AG | 2-aminooxazolines as taar1 ligands for cns disorders |
| CA2678072A1 (en) * | 2007-02-13 | 2008-08-21 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| CA2678069A1 (en) * | 2007-02-13 | 2008-08-21 | Schering Corporation | Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| WO2008100456A2 (en) * | 2007-02-13 | 2008-08-21 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| ES2525229T3 (es) * | 2007-02-15 | 2014-12-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolinas como ligandos de TAAR1 |
| EP2173720A2 (en) | 2007-07-02 | 2010-04-14 | F. Hoffmann-Roche AG | 2-imidazolines having a good affinity to the trace amine associated receptors (taars) |
| EP2173719A1 (en) * | 2007-07-03 | 2010-04-14 | F. Hoffmann-Roche AG | 4-imidazolines and their use as antidepressants |
| CA2694362A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| CA2695071A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of cns disorders |
| JP5341084B2 (ja) * | 2007-08-03 | 2013-11-13 | エフ.ホフマン−ラ ロシュ アーゲー | Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体 |
| CL2008003553A1 (es) * | 2007-12-05 | 2009-11-27 | Grindeks Jsc | Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso |
| WO2009105504A2 (en) | 2008-02-21 | 2009-08-27 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| RU2513086C2 (ru) * | 2008-07-24 | 2014-04-20 | Ф.Хоффманн-Ля Рош Аг | Производные 4,5-дигидро-оксазол-2-ила |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US20110190247A1 (en) * | 2008-08-04 | 2011-08-04 | Schering Corporation | Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| EP2356106A1 (en) | 2008-10-07 | 2011-08-17 | Schering Corporation | Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US8673950B2 (en) | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
| US8802673B2 (en) | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
| US9073911B2 (en) | 2011-06-09 | 2015-07-07 | Hoffmann-La Roche Inc. | Pyrazole derivatives |
| US9029370B2 (en) | 2011-06-10 | 2015-05-12 | Hoffmann-La Roche Inc. | Substituted benzamide derivatives |
| BR112014015832A8 (pt) | 2012-01-12 | 2017-07-04 | Hoffmann La Roche | derivados heterocíclicos como receptores associados com aminas vistigiais (taars) |
| SG11201501958QA (en) | 2012-09-14 | 2015-04-29 | Hoffmann La Roche | Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease |
| CN104603129A (zh) * | 2012-09-17 | 2015-05-06 | 霍夫曼-拉罗奇有限公司 | 三唑甲酰胺衍生物 |
| WO2015165085A1 (en) | 2014-04-30 | 2015-11-05 | F.Hoffmann-La Roche Ag | Morpholin-pyridine derivatives |
| CN106470994B (zh) | 2014-08-27 | 2019-09-24 | 豪夫迈·罗氏有限公司 | 用于治疗cns疾病的取代的吡嗪并[2,1-a]异喹啉衍生物 |
| EP3186224B1 (en) | 2014-08-27 | 2021-04-21 | F. Hoffmann-La Roche AG | Substituted azetidine derivatives as taar ligands |
| CA3017751A1 (en) * | 2016-03-17 | 2017-09-21 | Fmc Corporation | Process for converting s-enantiomer to its racemic form |
| KR102537050B1 (ko) | 2016-03-17 | 2023-05-26 | 에프. 호프만-라 로슈 아게 | Taar의 작용제로서 활성을 갖는 5-에틸-4-메틸-피라졸-3-카복스아미드 유도체 |
| CN116496261B (zh) * | 2023-03-09 | 2025-06-27 | 中国人民解放军军事科学院军事医学研究院 | 4-(1h)-咪唑类衍生物及其医药用途 |
| CN118684628B (zh) * | 2024-05-20 | 2025-06-17 | 中国人民解放军军事科学院军事医学研究院 | 取代二氢茚基咪唑类化合物及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6048972A (ja) * | 1983-08-25 | 1985-03-16 | Dai Ichi Seiyaku Co Ltd | テトラヒドロナフタレン誘導体 |
| GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB8626287D0 (en) * | 1986-11-04 | 1986-12-03 | Ucb Sa | Substituted 1h-imidazoles |
| GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| US5151526A (en) * | 1990-10-11 | 1992-09-29 | The United States Of America As Represented By The Secretary Of The Army | 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic |
| JPH04210680A (ja) * | 1990-12-01 | 1992-07-31 | Nissan Chem Ind Ltd | イミダゾール誘導体および植物生長調節剤 |
| GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
-
1994
- 1994-12-14 GB GBGB9425211.1A patent/GB9425211D0/en active Pending
-
1995
- 1995-12-05 MX MX9505063A patent/MX9505063A/es not_active IP Right Cessation
- 1995-12-08 BG BG100208A patent/BG63043B1/bg unknown
- 1995-12-08 IS IS4311A patent/IS4311A/is unknown
- 1995-12-08 PL PL95311736A patent/PL311736A1/xx unknown
- 1995-12-08 TW TW084113098A patent/TW303362B/zh active
- 1995-12-08 US US08/569,947 patent/US5658938A/en not_active Expired - Fee Related
- 1995-12-08 RO RO95-02138A patent/RO113346B1/ro unknown
- 1995-12-11 IL IL11632595A patent/IL116325A/xx not_active IP Right Cessation
- 1995-12-11 FI FI955927A patent/FI955927A7/fi unknown
- 1995-12-11 SK SK1550-95A patent/SK155095A3/sk unknown
- 1995-12-11 NZ NZ280646A patent/NZ280646A/en unknown
- 1995-12-12 EE EE9500064A patent/EE9500064A/xx unknown
- 1995-12-12 AR ARP950100512A patent/AR002257A1/es unknown
- 1995-12-12 ZA ZA9510554A patent/ZA9510554B/xx unknown
- 1995-12-12 AU AU40368/95A patent/AU693614B2/en not_active Ceased
- 1995-12-12 CZ CZ953271A patent/CZ327195A3/cs unknown
- 1995-12-12 HU HU9503549A patent/HUT73980A/hu unknown
- 1995-12-12 CN CN95120834A patent/CN1054376C/zh not_active Expired - Fee Related
- 1995-12-12 NO NO955034A patent/NO305316B1/no not_active IP Right Cessation
- 1995-12-13 CA CA002165133A patent/CA2165133A1/en not_active Abandoned
- 1995-12-13 RU RU95120582/04A patent/RU2156239C2/ru active
- 1995-12-13 JP JP7324502A patent/JPH08208622A/ja active Pending
- 1995-12-13 BR BR9505815A patent/BR9505815A/pt not_active Application Discontinuation
- 1995-12-13 EP EP95870132A patent/EP0717037A1/fr not_active Withdrawn
- 1995-12-14 KR KR1019950049572A patent/KR960022474A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IS4311A (is) | 1996-06-15 |
| RU2156239C2 (ru) | 2000-09-20 |
| IL116325A0 (en) | 1996-03-31 |
| NO955034L (no) | 1996-06-17 |
| US5658938A (en) | 1997-08-19 |
| HU9503549D0 (en) | 1996-02-28 |
| IL116325A (en) | 1999-10-28 |
| FI955927A0 (fi) | 1995-12-11 |
| EE9500064A (et) | 1996-06-17 |
| AU693614B2 (en) | 1998-07-02 |
| MX9505063A (es) | 1997-01-31 |
| FI955927L (fi) | 1996-06-15 |
| PL311736A1 (en) | 1996-06-24 |
| JPH08208622A (ja) | 1996-08-13 |
| BG63043B1 (bg) | 2001-02-28 |
| KR960022474A (ko) | 1996-07-18 |
| NO305316B1 (no) | 1999-05-10 |
| CN1054376C (zh) | 2000-07-12 |
| BR9505815A (pt) | 1998-01-06 |
| AR002257A1 (es) | 1998-03-11 |
| GB9425211D0 (en) | 1995-02-15 |
| BG100208A (bg) | 1996-07-31 |
| FI955927A7 (fi) | 1996-06-15 |
| EP0717037A1 (fr) | 1996-06-19 |
| RO113346B1 (ro) | 1998-06-30 |
| NZ280646A (en) | 1996-08-27 |
| CZ327195A3 (en) | 1996-07-17 |
| CN1133837A (zh) | 1996-10-23 |
| NO955034D0 (no) | 1995-12-12 |
| SK155095A3 (en) | 1997-02-05 |
| AU4036895A (en) | 1996-06-20 |
| TW303362B (esLanguage) | 1997-04-21 |
| HUT73980A (en) | 1996-10-28 |
| CA2165133A1 (en) | 1996-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69530493D1 (en) | Ablationsgerät | |
| DE69512030D1 (en) | Cerebral-dilator | |
| ZA9510554B (en) | Substituted 1H-imidazoles | |
| DE59503739D1 (en) | Polymer-sensor | |
| EP0778836A4 (en) | 9-SUBSTITUTED ALKYLADENINS | |
| DE69529159D1 (en) | Hüftgelenkprothese | |
| DE69502271D1 (en) | Afterabtrennung | |
| DE69504528D1 (en) | Quenchkühler | |
| DE69511086D1 (en) | Pyrimidinderivate | |
| DE69429543D1 (en) | Koagulationszange | |
| DE59503634D1 (en) | Friercontainer | |
| HU9502378D0 (en) | Substituted biphenyl-oxazolinones | |
| ZA954095B (en) | Substituted 3-phenylpyrazoles | |
| DE69512382D1 (en) | Deodorierte thermoplaste | |
| DE59509661D1 (en) | Heterocyclylbenzonitrile | |
| ZA956011B (en) | Substituted triazolylmethylphenylnaphthyridones | |
| ZA954546B (en) | Substituted 3-phenylpyrazoles | |
| AU122938S (en) | Breadbox | |
| DE69517886D1 (en) | Spiropyranverbindung | |
| DE69517588D1 (en) | Gekühlter transportcontainer | |
| DE69508761D1 (en) | Haloalkylierungsverfahren | |
| DE59508136D1 (en) | Phenylthio-oxazolin-derivate | |
| DE69506730D1 (en) | Differentialer antriebsmechanismus | |
| DE69527047D1 (en) | Bisazoverbindung | |
| ZA951092B (en) | Substituted oxazacycloalkenes |